AIP
ARIA

Ameritas Investment Partners’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Ameritas Investment Partners’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,280
Closed -$190K – 2965
2016
Q4 		$190K Hold
15,280
– – 0.01% 1035
2016
Q3 		$209K Buy
15,280
+1,493
+11% +$15K 0.01% 993
2016
Q2 		$102K Buy
13,787
+866
+7% +$6.5K 0.01% 997
2016
Q1 		$83K Hold
12,921
– – 0.01% 998
2015
Q4 		$81K Hold
12,921
– – 0.01% 996
2015
Q3 		$75K Hold
12,921
– – 0.01% 986
2015
Q2 		$107K Sell
12,921
-1,850
-13% -$16.4K 0.01% 1011
2015
Q1 		$122K Hold
14,771
– – 0.01% 1046
2014
Q4 		$101K Hold
14,771
– – 0.01% 1037
2014
Q3 		$80K Hold
14,771
– – 0.01% 1017
2014
Q2 		$94K Buy
+14,771
New +$102K 0.01% 1047

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Ameritas Investment Partners's ARIA Position: Q1 2017 in Review

Ameritas Investment Partners sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 15,280 shares — an estimated $190K sold.

Ameritas Investment Partners first reported a position in ARIA in Q2 2014 and held it in 11 quarters. The position peaked at $209K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Ameritas Investment Partners reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Ameritas Investment Partners sold 15,280 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $190K.
  • Ameritas Investment Partners first reported a position in Ariad Pharmaceuticals Inc in Q2 2014 and held it in 11 quarters.
  • Ameritas Investment Partners's Ariad Pharmaceuticals Inc position peaked at $209K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Ameritas Investment Partners's 13F filing for Q1 2017, filed 9 May 2017.